<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zang Y</submitter><funding>Tippins Foundation</funding><funding>NIDDK NIH HHS</funding><funding>UPMC Hillman Cancer Center Animal Facility and the Tissue and Research Pathology Services</funding><funding>NCI NIH HHS</funding><funding>Mellam Family Foundation</funding><funding>NIGMS NIH HHS</funding><pagination>198-207</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5761340</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>415</volume><pubmed_abstract>ELL2 is an androgen-responsive gene that is expressed by prostate epithelial cells and is frequently down-regulated in prostate cancer. Deletion of Ell2 in the murine prostate induced murine prostatic intraepithelial neoplasia and ELL2 knockdown enhanced proliferation and migration in C4-2 prostate cancer cells. Here, knockdown of ELL2 sensitized prostate cancer cells to DNA damage and overexpression of ELL2 protected prostate cancer cells from DNA damage. Knockdown of ELL2 impaired non-homologous end joining repair but not homologous recombination repair. Transfected ELL2 co-immunoprecipitated with both Ku70 and Ku80 proteins. ELL2 could bind to and co-accumulate with Ku70/Ku80 proteins at sites of DNA damage. Knockdown of ELL2 dramatically inhibited Ku70 and Ku80 recruitment and retentio</pubmed_abstract><journal>Cancer letters</journal><pubmed_title>ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.</pubmed_title><pmcid>PMC5761340</pmcid><funding_grant_id>R01 GM118833</funding_grant_id><funding_grant_id>P30 CA047904</funding_grant_id><funding_grant_id>1R50CA211242</funding_grant_id><funding_grant_id>P50 CA180995</funding_grant_id><funding_grant_id>P30CA047904</funding_grant_id><funding_grant_id>9R01CA186780</funding_grant_id><funding_grant_id>T32 DK007774</funding_grant_id><funding_grant_id>1P50CA180995</funding_grant_id><funding_grant_id>R50 CA211242</funding_grant_id><funding_grant_id>R01 CA186780</funding_grant_id><pubmed_authors>Xue B</pubmed_authors><pubmed_authors>Nelson JB</pubmed_authors><pubmed_authors>Zang Y</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Ai J</pubmed_authors><pubmed_authors>Shan Y</pubmed_authors><pubmed_authors>Qiu X</pubmed_authors><pubmed_authors>Pascal LE</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Lan L</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Wei L</pubmed_authors><pubmed_authors>Zhong M</pubmed_authors></additional><is_claimable>false</is_claimable><name>ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.</name><description>ELL2 is an androgen-responsive gene that is expressed by prostate epithelial cells and is frequently down-regulated in prostate cancer. Deletion of Ell2 in the murine prostate induced murine prostatic intraepithelial neoplasia and ELL2 knockdown enhanced proliferation and migration in C4-2 prostate cancer cells. Here, knockdown of ELL2 sensitized prostate cancer cells to DNA damage and overexpression of ELL2 protected prostate cancer cells from DNA damage. Knockdown of ELL2 impaired non-homologous end joining repair but not homologous recombination repair. Transfected ELL2 co-immunoprecipitated with both Ku70 and Ku80 proteins. ELL2 could bind to and co-accumulate with Ku70/Ku80 proteins at sites of DNA damage. Knockdown of ELL2 dramatically inhibited Ku70 and Ku80 recruitment and retentio</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Feb</publication><modification>2026-05-06T00:21:51.994Z</modification><creation>2019-08-04T07:05:39Z</creation></dates><accession>S-EPMC5761340</accession><cross_references><pubmed>29179998</pubmed><doi>10.1016/j.canlet.2017.11.028</doi></cross_references></HashMap>